AlzeCure Pharma: AlzeCure gets Late Breaking Abstract Accept

AlzeCure Pharma: AlzeCure gets Late Breaking Abstract Accepted on NeuroRestore's Positive Effect on Mitochondrial Function

STOCKHOLM, SWEDEN / ACCESSWIRE / January 11, 2022 / AlzeCure Pharma (STO:ALZCUR) (FRA:AC6)AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops a broad portfolio of small molecule

Related Keywords

Sweden , Stockholm , Swedish , Pontus Forsell , Gunnar Nordvall , Cristina Parrado Fern , Alzecure Pharma , Johan Sandin , , Nasdaq First North Premier Growth Market , Nerve Growth Factor , Brain Derived Neurotrophic Factor , Alzecure , Dharma , Jets , Gate , Breaking , Abstract , Accepted , Neurorestore , Positive , Effect , Mitochondrial , Junction ,